Accretion Pharmaceuticals Limited
Accretion Pharmaceuticals Limited, established in 2012, produces and sells tablets, capsules, and healthcare products, offering both generic and branded formulations. It provides contract manufacturing services for domestic and international clients, including government and private institutions.
What Accretion files
- Others33
- Investor Meet12
- Updates8
- Important3
- Board Meeting2
- PPTs2
Accretion Pharmaceuticals announced it is not classified as a Large Corporate, exempting it from specific compliance and disclosure rules related to raising funds via debt securities.
Accretion Pharmaceuticals announced its 2nd Annual General Meeting. The Annual Report for FY2024-25 and AGM Notice are now accessible. Shareholders not registered for electronic communications received direct access details.
Accretion Pharma's board appointed two independent directors, bolstering oversight. Statutory auditors were re-appointed, and an Executive Director was re-designated. A new experienced Company Secretary was appointed following a resignation. An Annual General Meeting is planned for shareholder approvals.